25 March 2026
YOUNG & CO.’S BREWERY, P.L.C. (“Young’s” or the “Company”) UPDATE ON MOVE TO THE MAIN MARKET Young’s, the premium operator of pubs and bedrooms…
24 March 2026
M.P. EVANS GROUP PLC FINAL RESULTS 2025 ANOTHER YEAR OF RECORD PROFITS AND INCREASING SHAREHOLDER RETURNS M.P. Evans Group PLC (“M.P. Evans”, “the Group”…
Fevertree Drinks plc FY25 Preliminary Results to 31 December 2025 Positive strategic progress during the year Comfortable with market expectations for 2026 Highlights £m…
23 March 2026
Trading Update March 2026 It is encouraging that the Group’s trading performance remains in line with expectations, as outlined in the October 2025 trading…
GSK’s B7-H3-targeted antibody-drug conjugate, risvutatug rezetecan, granted Orphan Drug Designation for small-cell lung cancer in Japan GSK plc (LSE/NYSE: GSK) today announced that risvutatug rezetecan…
20 March 2026
Unilever PLC Response to media speculation Unilever notes recent media speculation regarding a potential transaction involving its Foods business. The Board believes Foods is…
Ecclesiastical Insurance Office public limited company announces results for the yearended 31 December 2025 Ecclesiastical Insurance Office public limited company (‘Ecclesiastical’, ‘EIO’ or ‘the…
19 March 2026
JPMORGAN GLOBAL GROWTH & INCOME PLC UNAUDITED HALF YEAR RESULTS FOR THE SIX MONTHS ENDED 31ST DECEMBER 2025 JPMorgan Global Growth & Income plc…